Nektar TherapeuticsNKTRNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank43
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-131.39M
Near historical average
Percentile
P43
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-136.49M
Historical baseline
PeriodValueYoY Change
TTM$-131.39M-24.9%
2024$-105.20M+23.5%
2023$-137.43M+42.8%
2022$-240.24M+46.1%
2021$-446.10M-17.4%
2020$-379.92M+13.7%
2019$-440.04M-164.0%
2018$687.93M+1253.4%
2017$-59.64M+47.2%
2016$-112.86M-